Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | MAP1LC3B | Q9GZQ8 | 1/20 | 0.35 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.35 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26976730 | 0.84 | GSK3B (0.43) | SMN1; SMN2GAAALDH1A1CYP2C19NPSR1 | |
| SCHEMBL26976667 | 0.84 | LMNA (0.43) | SMN1; SMN2GAACYP3A4CYP2C9MAPT | |
| SCHEMBL26976689 | 0.84 | LIG1 (0.42) | SMN1; SMN2GAAALDH1A1MEN1KMT2A | |
| SCHEMBL18590510 | 0.84 | SMN1; SMN2 (0.50) | SMN1; SMN2GAAALDH1A1MEN1KMT2A | |
| SCHEMBL26976625 | 0.84 | SMN1; SMN2 (0.50) | SMN1; SMN2GAAALDH1A1MEN1KMT2A | |
| SCHEMBL26976946 | 0.83 | CRBN (0.43) | SMN1; SMN2GAAALDH1A1MEN1KMT2A | |
| SCHEMBL26976633 | 0.81 | DDB1 (0.48) | SMN1; SMN2GAAALDH1A1MEN1KMT2A | |
| SCHEMBL26976903 | 0.80 | CYP3A4 (0.43) | SMN1; SMN2GAAMEN1KMT2ACYP3A4 | |
| SCHEMBL26976795 | 0.80 | L3MBTL1 (0.44) | SMN1; SMN2GAAMEN1KMT2ACYP3A4 | |
| SCHEMBL19862623 | 0.78 | SMN1; SMN2 (0.40) | SMN1; SMN2GAAALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240188565-A1 | GLOBODERA PALLIDA CONTROL AGENT | NATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION (JP) | 2024-06-13 | — | — | US | claimed |
| EP-4298907-A1 | GLOBODERA PALLIDA CONTROL AGENT | NATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION (JP) | 2024-01-03 | — | — | EP | claimed |
| WO-2022181170-A1 | GLOBODERA PALLIDA CONTROL AGENT | 国立研究開発法人農業・食品産業技術総合研究機構 | 2022-09-01 | — | — | WO | claimed |
| US-20240188565-A1 | GLOBODERA PALLIDA CONTROL AGENT | NATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION (JP) | 2024-06-13 | — | — | US | disclosed |
| EP-4298907-A1 | GLOBODERA PALLIDA CONTROL AGENT | NATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION (JP) | 2024-01-03 | — | — | EP | disclosed |
| WO-2022181170-A1 | GLOBODERA PALLIDA CONTROL AGENT | 国立研究開発法人農業・食品産業技術総合研究機構 | 2022-09-01 | — | — | WO | disclosed |
| US-10029983-B2 | Urea derivative or pharmacologically acceptable salt thereof | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2018-07-24 | — | — | US | disclosed |
| US-20180044290-A1 | UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | KYORIN SEIYAKU KK (JP) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240188565-A1 | GLOBODERA PALLIDA CONTROL AGENT | GHRHR, BRIX1, RBX1 | SMN1; SMN2 322/4885GAA 549/4885ALDH1A1 1542/4885 |
| US-10029983-B2 | Urea derivative or pharmacologically acceptable salt thereof | FPR1, FPR2, FPR3 | SMN1; SMN2 3809/4885GAA 3976/4885ALDH1A1 2202/4885 |
| US-20180044290-A1 | UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | FPR1, FPR2, FPR3 | SMN1; SMN2 3809/4885GAA 3976/4885ALDH1A1 2202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.